Subscribe
shutterstock_1642888921_kira_yan
Kira Yan / Shutterstock.com
10 August 2020Big PharmaMuireann Bolger

Novavax partners with Takeda to deliver COVID-19 vaccine in Japan

US biotechnology company  Novavax has signed a deal with  Takeda Pharmaceuticals to develop,  manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
A new drug pricing system reform proposal in Japan
17 August 2021   A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.
Biotechnology
Novavax seals COVID-19 vaccine deal with Australia
5 November 2020   Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.
Generics
Second Circuit says Takeda can’t dodge two antitrust suits
26 August 2021   The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Generics
A new drug pricing system reform proposal in Japan
17 August 2021   A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.
Biotechnology
Novavax seals COVID-19 vaccine deal with Australia
5 November 2020   Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.
Generics
Second Circuit says Takeda can’t dodge two antitrust suits
26 August 2021   The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos.

More on this story

Generics
A new drug pricing system reform proposal in Japan
17 August 2021   A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.
Biotechnology
Novavax seals COVID-19 vaccine deal with Australia
5 November 2020   Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.
Generics
Second Circuit says Takeda can’t dodge two antitrust suits
26 August 2021   The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent